The impact of microglial activation on blood-brain barrier in brain diseases

Frontiers in Cellular Neuroscience

Volumn 8, Issue November, 2014, Pages 1-13

  da Fonseca, Anna Carolina Carvalho ^a   Matias, Diana ^a   Garcia, Celina ^a   Amaral, Rackele ^a   Geraldo, Luiz Henrique ^a   Freitas, Catarina ^a   Lima, Flavia Regina Souza ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Blood brain barrier; Brain diseases; Endothelium; Microglia; Microglial activation; Neuroinflammation

Indexed keywords

ADENOSINE TRIPHOSPHATE; CHEMOKINE RECEPTOR CCR2; CLAUDIN 5; CXCL1 CHEMOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GAMMA INTERFERON; GELATINASE A; GELATINASE B; HIGH MOBILITY GROUP B1 PROTEIN; HYPOXIA INDUCIBLE FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; OCCLUDIN; PADGEM PROTEIN; PROTEIN ZO1; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; STRESS ACTIVATED PROTEIN KINASE; STROMELYSIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN;

ALZHEIMER DISEASE; BLOOD BRAIN BARRIER; BRAIN DISEASE; BRAIN FUNCTION; CELL ACTIVATION; CELL INTERACTION; CEREBROVASCULAR ACCIDENT; ENDOTHELIUM; EPILEPSY; HUMAN; IMMUNE RESPONSE; MEMBRANE PERMEABILITY; MICROGLIA; MULTIPLE SCLEROSIS; NONHUMAN; OXIDATIVE STRESS; REVIEW; SIGNAL TRANSDUCTION; TRAUMATIC BRAIN INJURY;

EID: 84908654342     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2014.00362     Document Type: Review

References (184)

1. Adibhatla, R. M., Hatcher, J. F., and Dempsey, R. J. (2006). Lipids and lipidomics in brain injury and diseases.AAPS J. 8, E314-E321. doi: 10.1208/aapsj080236
2. Alliot, F., Godin, I., and Pessac, B. (1999). Microglia derive from progenitors, originating from the yolk sac and which proliferate in the brain. Brain Res. Dev. Brain Res. 117, 145-152. doi: 10.1016/s0165-3806(99)00113-3
3. Andjelkovic, A. V., Kerkovich, D., Shanley, J., Pulliam, L., and Pachter, J. S. (1999). Expression of binding sites for beta chemokines on human astrocytes. Glia 28, 225-235. doi: 10.1002/(sici)1098-1136(199912)28:3<225::aid-glia6>3.0.co;2-6
4. Andjelkovic, A. V., and Pachter, J. S. (2000). Characterization of binding sites for chemokines MCP-1 and MIP-1alpha on human brain microvessels. J. Neurochem. 75, 1898-1906. doi: 10.1046/j.1471-4159.2000.0751898.x
5. Arai, K., Lok, J., Guo, S., Hayakawa, K., Xing, C., and Lo, E. H. (2011). Cellular mechanisms of neurovascular damage and repair after stroke. J. Child Neurol. 26, 1193-1198. doi: 10.1177/0883073811408610
6. Armulik, A., Genové, G., Mäe, M., Nisancioglu, M. H., Wallgard, E., Niaudet, C., et al. (2010). Pericytes regulate the blood-brain barrier. Nature 468, 557-561. doi: 10.1038/nature09522
7. Aronica, E., Fluiter, K., Iyer, A., Zurolo, E., Vreijling, J., Van Vliet, E. A., et al. (2010). Expression pattern of miR-146a, an inflammation-associated microRNA, in experimental and human temporal lobe epilepsy. Eur. J. Neurosci.31, 1100-1107. doi: 10.1111/j.1460-9568.2010.07122.x
8. Aronica, E., Ravizza, T., Zurolo, E., and Vezzani, A. (2012). Astrocyte immune responses in epilepsy. Glia 60, 1258-1268. doi: 10.1002/glia.22312
9. Asahi, M., Wang, X., Mori, T., Sumii, T., Jung, J. C., Moskowitz, M. A., et al. (2001). Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J. Neurosci. 21, 7724-7732.
10. Bake, S., Selvamani, A., Cherry, J., and Sohrabji, F. (2014). Blood brain barrier and neuroinflammation are critical targets of IGF-1-mediated neuroprotection in stroke for middle-aged female rats. PLoS One 9:e91427. doi: 10.1371/journal.pone.0091427
11. Banisadr, G., Quéraud-Lesaux, F., Boutterin, M. C., Pélaprat, D., Zalc, B., Rostène, W., et al. (2002). Distribution, cellular localization and functional role of CCR2 chemokine receptors in adult rat brain. J. Neurochem. 81, 257-269. doi: 10.1046/j.1471-4159.2002.00809.x
12. Block, M. L., and Hong, J. S. (2005). Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog. Neurobiol. 76, 77-98. doi: 10.1016/j.pneurobio.2005.06.004
13. Bolton, S. J., Anthony, D. C., and Perry, V. H. (1998). Loss of the tight junction proteins occludin and zonula occludens-1 from cerebral vascular endothelium during neutrophil-induced blood-brain barrier breakdown in vivo. Neuroscience 86, 1245-1257. doi: 10.1016/s0306-4522(98)00058-x
14. Briones, T. L., Rogozinska, M., and Woods, J. (2011). Modulation of ischemia-induced NMDAR1 activation by environmental enrichment decreases oxidative damage. J. Neurotrauma 28, 2485-2492. doi: 10.1089/neu.2011.1842
15. Britschgi, M., and Wyss-Coray, T. (2007). Immune cells may fend off Alzheimer disease. Nat. Med. 13, 408-409. doi: 10.1038/nm0407-408
16. Brivet, F. G., Jacobs, F. M., and Mégarbane, B. (2005). Cerebral output of cytokines in patients with pneumococcal meningitis. Crit. Care Med. 33, 2721-2722; author reply 2722-2723. doi: 10.1097/01.ccm.0000187092.73841.82
17. Buckner, C. M., Luers, A. J., Calderon, T. M., Eugenin, E. A., and Berman, J. W. (2006). Neuroimmunity and the blood-brain barrier: molecular regulation of leukocyte transmigration and viral entry into the nervous system with a focus on neuroAIDS. J. Neuroimmune Pharmacol. 1, 160-181. doi: 10.1007/s11481-006-9017-3
18. Centonze, D., Muzio, L., Rossi, S., Furlan, R., Bernardi, G., and Martino, G. (2010). The link between inflammation, synaptic transmission and neurodegeneration in multiple sclerosis. Cell Death Differ. 17, 1083-1091. doi: 10.1038/cdd.2009.179
19. Checchin, D., Sennlaub, F., Levavasseur, E., Leduc, M., and Chemtob, S. (2006). Potential role of microglia in retinal blood vessel formation. Invest. Ophthalmol. Vis. Sci. 47, 3595-3602. doi: 10.1167/iovs.05-1522
20. Chodobski, A., Zink, B. J., and Szmydynger-Chodobska, J. (2011). Blood-brain barrier pathophysiology in traumatic brain injury. Transl. Stroke Res. 2, 492-516. doi: 10.1007/s12975-011-0125-x
21. Coulter, D. A., and Eid, T. (2012). Astrocytic regulation of glutamate homeostasis in epilepsy. Glia 60, 1215-1226. doi: 10.1002/glia.22341
22. Crow, A. R., Song, S., Semple, J. W., Freedman, J., and Lazarus, A. H. (2007). A role for IL-1 receptor antagonist or other cytokines in the acute therapeutic effects of IVIg? Blood 109, 155-158. doi: 10.1182/blood-2006-05-023796
23. Cuadros, M. A., Martin, C., Coltey, P., Almendros, A., and Navascués, J. (1993). First appearance, distribution and origin of macrophages in the early development of the avian central nervous system. J. Comp. Neurol. 330, 113-129. doi: 10.1002/cne.903300110
24. Cunningham, A. S., Salvador, R., Coles, J. P., Chatfield, D. A., Bradley, P. G., Johnston, A. J., et al. (2005). Physiological thresholds for irreversible tissue damage in contusional regions following traumatic brain injury.Brain 128, 1931-1942. doi: 10.1093/brain/awh536
25. Daneman, R., Zhou, L., Kebede, A. A., and Barres, B. A. (2010). Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature 468, 562-566. doi: 10.1038/nature09513
26. Davalos, D., Ryu, J. K., Merlini, M., Baeten, K. M., Le Moan, N., Petersen, M. A., et al. (2012). Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation. Nat. Commun. 3:1227. doi: 10.1038/ncomms2230
27. Defaux, A., Zurich, M. G., Honegger, P., and Monnet-Tschudi, F. (2011). Minocycline promotes remyelination in aggregating rat brain cell cultures after interferon-γ plus lipopolysaccharide-induced demyelination. Neuroscience187, 84-92. doi: 10.1016/j.neuroscience.2011.04.053
28. Denes, A., Thornton, P., Rothwell, N. J., and Allan, S. M. (2010). Inflammation and brain injury: acute cerebral ischaemia, peripheral and central inflammation. Brain Behav. Immun. 24, 708-723. doi: 10.1016/j.bbi.2009.09.010
29. Denes, A., Vidyasagar, R., Feng, J., Narvainen, J., McColl, B. W., Kauppinen, R. A., et al. (2007). Proliferating resident microglia after focal cerebral ischaemia in mice. J. Cereb. Blood Flow Metab. 27, 1941-1953. doi: 10.1038/sj.jcbfm.9600495
30. Denieffe, S., Kelly, R. J., McDonald, C., Lyons, A., and Lynch, M. A. (2013). Classical activation of microglia in CD200-deficient mice is a consequence of blood brain barrier permeability and infiltration of peripheral cells.Brain Behav. Immun. 34, 86-97. doi: 10.1016/j.bbi.2013.07.174
31. Dickstein, D. L., Biron, K. E., Ujiie, M., Pfeifer, C. G., Jeffries, A. R., and Jefferies, W. A. (2006). Abeta peptide immunization restores blood-brain barrier integrity in Alzheimer disease. FASEB J. 20, 426-433. doi: 10.1096/fj.05-3956com
32. Dimitrijevic, O. B., Stamatovic, S. M., Keep, R. F., and Andjelkovic, A. V. (2006). Effects of the chemokine CCL2 on blood-brain barrier permeability during ischemia-reperfusion injury. J. Cereb. Blood Flow Metab. 26, 797-810. doi: 10.1038/sj.jcbfm.9600229
33. Downes, C. E., and Crack, P. J. (2010). Neural injury following stroke: are toll-like receptors the link between the immune system and the CNS? Br. J. Pharmacol. 160, 1872-1888. doi: 10.1111/j.1476-5381.2010.00864.x
34. Dubé, C. M., Ravizza, T., Hamamura, M., Zha, Q., Keebaugh, A., Fok, K., et al. (2010). Epileptogenesis provoked by prolonged experimental febrile seizures: mechanisms and biomarkers. J. Neurosci. 30, 7484-7494. doi: 10.1523/JNEUROSCI.0551-10.2010
35. Eikelenboom, P., Veerhuis, R., van Exel, E., Hoozemans, J. J., Rozemuller, A. J., and van Gool, W. A. (2011). The early involvement of the innate immunity in the pathogenesis of late-onset Alzheimer's disease: neuropathological, epidemiological and genetic evidence. Curr. Alzheimer Res. 8, 142-150. doi: 10.2174/156720511795256080
36. Ekdahl, C. T., Kokaia, Z., and Lindvall, O. (2009). Brain inflammation and adult neurogenesis: the dual role of microglia. Neuroscience 158, 1021-1029. doi: 10.1016/j.neuroscience.2008.06.052
37. El Khoury, J., Toft, M., Hickman, S. E., Means, T. K., Terada, K., Geula, C., et al. (2007). Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat. Med. 13, 432-438. doi: 10.1038/nm1555
38. Enzmann, G., Mysiorek, C., Gorina, R., Cheng, Y. J., Ghavampour, S., Hannocks, M. J., et al. (2013). The neurovascular unit as a selective barrier to polymorphonuclear granulocyte (PMN) infiltration into the brain after ischemic injury. Acta Neuropathol. 125, 395-412. doi: 10.1007/s00401-012-1076-3
39. Erickson, M. A., and Banks, W. A. (2013). Blood-brain barrier dysfunction as a cause and consequence of Alzheimer's disease. J. Cereb. Blood Flow Metab. 33, 1500-1513. doi: 10.1038/jcbfm.2013.135
40. Espinosa-Heidmann, D. G., Suner, I. J., Hernandez, E. P., Monroy, D., Csaky, K. G., and Cousins, S. W. (2003). Macrophage depletion diminishes lesion size and severity in experimental choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 44, 3586-3592. doi: 10.1167/iovs.03-0038
41. Eugenin, E. A., Clements, J. E., Zink, M. C., and Berman, J. W. (2011). Human immunodeficiency virus infection of human astrocytes disrupts blood-brain barrier integrity by a gap junction-dependent mechanism. J. Neurosci. 31, 9456-9465. doi: 10.1523/JNEUROSCI.1460-11.2011
42. Fabene, P. F., Navarro Mora, G., Martinello, M., Rossi, B., Merigo, F., Ottoboni, L., et al. (2008). A role for leukocyte-endothelial adhesion mechanisms in epilepsy. Nat. Med. 14, 1377-1383. doi: 10.1038/nm.1878.
43. Fagan, S. C., Cronic, L. E., and Hess, D. C. (2011). Minocycline development for acute ischemic stroke. Transl. Stroke Res. 2, 202-208. doi: 10.1007/s12975-011-0072-6
44. Fantin, A., Vieira, J. M., Gestri, G., Denti, L., Schwarz, Q., Prykhozhij, S., et al. (2010). Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction. Blood116, 829-840. doi: 10.1182/blood-2009-12-257832
45. Fischer, M. T., Sharma, R., Lim, J. L., Haider, L., Frischer, J. M., Drexhage, J., et al. (2012). NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury.Brain 135, 886-899. doi: 10.1093/brain/aws012
46. Fisher, R. S., van Emde Boas, W., Blume, W., Elger, C., Genton, P., Lee, P., et al. (2005). Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 46, 470-472. doi: 10.1111/j.0013-9580.2005.66104.x
47. Fujiwara, N., and Kobayashi, K. (2005). Macrophages in inflammation. Curr. Drug Targets Inflamm. Allergy 4, 281-286. doi: 10.2174/1568010054022024
48. Ge, S., Song, L., Serwanski, D. R., Kuziel, W. A., and Pachter, J. S. (2008). Transcellular transport of CCL2 across brain microvascular endothelial cells. J. Neurochem. 104, 1219-1232. doi: 10.1111/j.1471-4159.2007.05056.x
49. Gerhardt, H., Golding, M., Fruttiger, M., Ruhrberg, C., Lundkvist, A., Abramsson, A., et al. (2003). VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J. Cell Biol. 161, 1163-1177. doi: 10.1083/jcb.200302047
50. Ginhoux, F., Greter, M., Leboeuf, M., Nandi, S., See, P., and Gokhan, S. (2010). Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330, 841-845. doi: 10.1126/science.1194637
51. Glimåker, M., Kragsbjerg, P., Forsgren, M., and Olcén, P. (1993). Tumor necrosis factor-alpha (TNF alpha) in cerebrospinal fluid from patients with meningitis of different etiologies: high levels of TNF alpha indicate bacterial meningitis. J. Infect. Dis. 167, 882-889. doi: 10.1093/infdis/167.4.882
52. Gottschall, P. E., and Deb, S. (1996). Regulation of matrix metalloproteinase expressions in astrocytes, microglia and neurons. Neuroimmunomodulation 3, 69-75. doi: 10.1159/000097229
53. Graeber, M. B., Li, W., and Rodriguez, M. L. (2011). Role of microglia in CNS inflammation. FEBS Lett. 585, 3798-3805. doi: 10.1016/j.febslet.2011.08.033
54. Grammas, P. (2011). Neurovascular dysfunction, inflammation and endothelial activation: implications for the pathogenesis of Alzheimer's disease. J. Neuroinflammation 8:26. doi: 10.1186/1742-2094-8-26
55. Gu, Y., Zheng, G., Xu, M., Li, Y., Chen, X., Zhu, W., et al. (2012). Caveolin-1 regulates nitric oxide-mediated matrix metalloproteinases activity and blood-brain barrier permeability in focal cerebral ischemia and reperfusion injury.J. Neurochem. 120, 147-156. doi: 10.1111/j.1471-4159.2011.07542.x
56. Hallenbeck, J. M. (2002). The many faces of tumor necrosis factor in stroke. Nat. Med. 8, 1363-1368. doi: 10.1038/nm1202-1363
57. Hanisch, U. K., and Kettenmann, H. (2007). Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 10, 1387-1394. doi: 10.1038/nn1997
58. Holman, D. W., Klein, R. S., and Ransohoff, R. M. (2011). The blood-brain barrier, chemokines and multiple sclerosis. Biochim. Biophys. Acta 1812, 220-230. doi: 10.1016/j.bbadis.2010.07.019
59. Holmes, C. (2013). Review: systemic inflammation and Alzheimer's disease. Neuropathol. Appl. Neurobiol. 39, 51-68. doi: 10.1111/j.1365-2990.2012.01307.x
60. Huang, C. Y., Chen, Y. L., Li, A. H., Lu, J. C., and Wang, H. L. (2014). Minocycline, a microglial inhibitor, blocks spinal CCL2-induced heat hyperalgesia and augmentation of glutamatergic transmission in substantia gelatinosa neurons. J. Neuroinflammation 11:7. doi: 10.1186/1742-2094-11-7
61. Huang, C. F., Li, G., Ma, R., Sun, S. G., and Chen, J. G. (2008b). Thrombin-induced microglial activation contributes to the degeneration of nigral dopaminergic neurons in vivo. Neurosci. Bull. 24, 66-72. doi: 10.1007/s12264-008-0066-x
62. Huang, C., Ma, R., Sun, S., Wei, G., Fang, Y., Liu, R., et al. (2008a). JAK2-STAT3 signaling pathway mediates thrombin-induced proinflammatory actions of microglia in vitro. J. Neuroimmunol. 204, 118-125. doi: 10.1016/j.jneuroim.2008.07.004
63. Huber, J. D., Campos, C. R., Mark, K. S., and Davis, T. P. (2006). Alterations in blood-brain barrier ICAM-1 expression and brain microglial activation after lambda-carrageenan-induced inflammatory pain. Am. J. Physiol. Heart Circ. Physiol. 290, H732-H740. doi: 10.1152/ajpheart.00747.2005
64. Iadecola, C. (2004). Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat. Rev. Neurosci.5, 347-360. doi: 10.1038/nrn1387
65. Janzer, R. C., and Raff, M. C. (1987). Astrocytes induce blood-brain barrier properties in endothelial cells. Nature325, 253-257. doi: 10.1038/325253a0
66. Jiao, H., Wang, Z., Liu, Y., Wang, P., and Xue, Y. (2011). Specific role of tight junction proteins claudin-5, occludin and ZO-1 of the blood-brain barrier in a focal cerebral ischemic insult. J. Mol. Neurosci. 44, 130-139. doi: 10.1007/s12031-011-9496-4
67. Jin, R., Yang, G., and Li, G. (2010). Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J. Leukoc. Biol. 87, 779-789. doi: 10.1189/jlb.1109766
68. Kadhim, H. J., Duchateau, J., and Sébire, G. (2008). Cytokines and brain injury: invited review. J. Intensive Care Med. 23, 236-249. doi: 10.1177/0885066608318458
69. Kettenmann, H., Hanisch, U. K., Noda, M., and Verkhratsky, A. (2011). Physiology of microglia. Physiol. Rev. 91, 461-553. doi: 10.1152/physrev.00011.2010
70. Kim, J. V., Kang, S. S., Dustin, M. L., and McGavern, D. B. (2009). Myelomonocytic cell recruitment causes fatal CNS vascular injury during acute viral meningitis. Nature 457, 191-195. doi: 10.1038/nature07591
71. Kitamura, Y., Takata, K., Inden, M., Tsuchiya, D., Yanagisawa, D., Nakata, J., et al. (2004). Intracerebroventricular injection of microglia protects against focal brain ischemia. J. Pharmacol. Sci. 94, 203-206. doi: 10.1254/jphs.94.203
72. Kiyota, T., Gendelman, H. E., Weir, R. A., Higgins, E. E., Zhang, G., and Jain, M. (2013). CCL2 affects β-amyloidosis and progressive neurocognitive dysfunction in a mouse model of Alzheimer's disease. Neurobiol. Aging 34, 1060-1068. doi: 10.1016/j.neurobiolaging.2012.08.009
73. Kobayashi, K., Imagama, S., Ohgomori, T., Hirano, K., Uchimura, K., Sakamoto, K., et al. (2013). Minocycline selectively inhibits M1 polarization of microglia. Cell Death Dis. 4:e525. doi: 10.1038/cddis.2013.54
74. Kofuji, P., and Newman, E. A. (2004). Potassium buffering in the central nervous system. Neuroscience 129, 1045-1056. doi: 10.1016/j.neuroscience.2004.06.008
75. Koistinaho, M., Malm, T. M., Kettunen, M. I., Goldsteins, G., Starckx, S., Kauppinen, R. A., et al. (2005). Minocycline protects against permanent cerebral ischemia in wild type but not in matrix metalloprotease-9-deficient mice. J. Cereb. Blood Flow Metab. 25, 460-467. doi: 10.1038/sj.jcbfm.9600040
76. Kooij, G., Mizee, M. R., van Horssen, J., Reijerkerk, A., Witte, M. E., Drexhage, J. A., et al. (2011). Adenosine triphosphate-binding cassette transporters mediate chemokine (C-C motif) ligand 2 secretion from reactive astrocytes: relevance to multiple sclerosis pathogenesis. Brain 134, 555-570. doi: 10.1093/brain/awq330
77. Kreutzberg, G. W. (1996). Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19, 312-318. doi: 10.1016/0166-2236(96)10049-7
78. Kunsch, C., and Medford, R. M. (1999). Oxidative stress as a regulator of gene expression in the vasculature. Circ. Res. 85, 753-766. doi: 10.1161/01.res.85.8.753
79. Lalancette-Hébert, M., Gowing, G., Simard, A., Weng, Y. C., and Kriz, J. (2007). Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain. J. Neurosci. 27, 2596-2605. doi: 10.1523/jneurosci.5360-06.2007
80. Larochelle, C., Alvarez, J. I., and Prat, A. (2011). How do immune cells overcome the blood-brain barrier in multiple sclerosis? FEBS Lett. 585, 3770-3780. doi: 10.1016/j.febslet.2011.04.066
81. Lassman, M. E., McLaughlin, T. M., Somers, E. P., Stefanni, A. C., Chen, Z., Murphy, B. A., et al. (2012). A rapid method for cross-species quantitation of apolipoproteins A1, B48 and B100 in plasma by ultra-performance liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass Spectrom. 26, 101-108. doi: 10.1002/rcm.5296
82. Lassmann, H., van Horssen, J., and Mahad, D. (2012). Progressive multiple sclerosis: pathology and pathogenesis.Nat. Rev. Neurol. 8, 647-656. doi: 10.1038/nrneurol.2012.168
83. Lenard, A., Ellertsdottir, E., Herwig, L., Krudewig, A., Sauteur, L., Belting, H. G., et al. (2013). In vivo analysis reveals a highly stereotypic morphogenetic pathway of vascular anastomosis. Dev. Cell 25, 492-506. doi: 10.1016/j.devcel.2013.05.010
84. Leppert, D., Leib, S. L., Grygar, C., Miller, K. M., Schaad, U. B., and Holländer, G. A. (2000). Matrix metalloproteinase (MMP)-8 and MMP-9 in cerebrospinal fluid during bacterial meningitis: association with blood-brain barrier damage and neurological sequelae. Clin. Infect. Dis. 31, 80-84. doi: 10.1086/313922
85. Li, D., Li, P., He, Z., Cen, D., Meng, Z., Liang, L., et al. (2012). Human intravenous immunoglobulins suppress seizure activities and inhibit the activation of GFAP-positive astrocytes in the hippocampus of picrotoxin-kindled rats. Int. J. Neurosci. 122, 200-208. doi: 10.3109/00207454.2011.639470
86. Li, S., Overman, J. J., Katsman, D., Kozlov, S. V., Donnelly, C. J., Twiss, J. L., et al. (2010). An age-related sprouting transcriptome provides molecular control of axonal sprouting after stroke. Nat. Neurosci. 13, 1496-1504. doi: 10.1038/nn.2674
87. Li, W. W., Setzu, A., Zhao, C., and Franklin, R. J. (2005). Minocycline-mediated inhibition of microglia activation impairs oligodendrocyte progenitor cell responses and remyelination in a non-immune model of demyelination. J. Neuroimmunol. 158, 58-66. doi: 10.1016/j.jneuroim.2004.08.011
88. Librizzi, L., Noè, F., Vezzani, A., de Curtis, M., and Ravizza, T. (2012). Seizure-induced brain-borne inflammation sustains seizure recurrence and blood-brain barrier damage. Ann. Neurol. 72, 82-90. doi: 10.1002/ana.23567
89. Liebner, S., Kniesel, U., Kalbacher, H., and Wolburg, H. (2000). Correlation of tight junction morphology with the expression of tight junction proteins in blood-brain barrier endothelial cells. Eur J. Cell Biol. 79, 707-717. doi: 10.1078/0171-9335-00101
90. Lindahl, P., Johansson, B. R., Levéen, P., and Betsholtz, C. (1997). Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 277, 242-245. doi: 10.1126/science.277.5323.242
91. Liu, S., Levine, S. R., and Winn, H. R. (2010). Targeting ischemic penumbra: part I-from pathophysiology to therapeutic strategy. J. Exp. Stroke Transl. Med. 3, 47-55. doi: 10.6030/1939-067x-3.1.47
92. Lo, E. H., Moskowitz, M. A., and Jacobs, T. P. (2005). Exciting, radical, suicidal: how brain cells die after stroke.Stroke 36, 189-192. doi: 10.1161/01.str.0000153069.96296.fd
93. Lochhead, J. J., McCaffrey, G., Quigley, C. E., Finch, J., DeMarco, K. M., Nametz, N., et al. (2010). Oxidative stress increases blood-brain barrier permeability and induces alterations in occludin during hypoxia-reoxygenation. J. Cereb. Blood Flow Metab. 30, 1625-1636. doi: 10.1038/jcbfm.2010.29
94. Lyros, E., Bakogiannis, C., Liu, Y., and Fassbender, K. (2014). Molecular links between endothelial dysfunction and neurodegeneration in Alzheimer's disease. Curr. Alzheimer Res. 11, 18-26. doi: 10.2174/1567205010666131119235254
95. Mahad, D. J., and Ransohoff, R. M. (2003). The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE). Semin. Immunol. 15, 23-32. doi: 10.1016/s1044-5323(02)00125-2
96. Maroso, M., Balosso, S., Ravizza, T., Iori, V., Wright, C. I., French, J., et al. (2011). Interleukin-1β biosynthesis inhibition reduces acute seizures and drug resistant chronic epileptic activity in mice. Neurotherapeutics 8, 304-315. doi: 10.1007/s13311-011-0039-z
97. Massberg, S., Brand, K., Grüner, S., Page, S., Müller, E., Müller, I., et al. (2002). A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J. Exp. Med. 196, 887-896. doi: 10.1084/jem.20012044
98. Mathiisen, T. M., Lehre, K. P., Danbolt, N. C., and Ottersen, O. P. (2010). The perivascular astroglial sheath provides a complete covering of the brain microvessels: an electron microscopic 3D reconstruction. Glia 58, 1094-1103. doi: 10.1002/glia.20990
99. McGeer, P. L., and McGeer, E. G. (1995). The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res. Brain Res. Rev. 21, 195-218. doi: 10.1016/0165-0173(95)00011-9
100. Mikati, M. A., Kurdi, R., El-Khoury, Z., Rahi, A., and Raad, W. (2010). Intravenous immunoglobulin therapy in intractable childhood epilepsy: open-label study and review of the literature. Epilepsy Behav. 17, 90-94. doi: 10.1016/j.yebeh.2009.10.020
101. Miron, V. E., Boyd, A., Zhao, J. W., Yuen, T. J., Ruckh, J. M., Shadrach, J. L., et al. (2013). M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination. Nat. Neurosci. 16, 1211-1218. doi: 10.1038/nn.3469
102. Mizee, M. R., and de Vries, H. E. (2013). Blood-brain barrier regulation: environmental cues controlling the onset of barrier properties. Tissue Barriers 1:e26882. doi: 10.4161/tisb.26882
103. Monson, N. L., Ireland, S. J., Ligocki, A. J., Chen, D., Rounds, W. H., Li, M., et al. (2014). Elevated CNS inflammation in patients with preclinical Alzheimer's disease. J. Cereb. Blood Flow Metab. 34, 30-33. doi: 10.1038/jcbfm.2013.183
104. Mook-Kanamori, B. B., Geldhoff, M., van der Poll, T., and van de Beek, D. (2011). Pathogenesis and pathophysiology of pneumococcal meningitis. Clin. Microbiol. Rev. 24, 557-591. doi: 10.1128/CMR.00008-11
105. Morin-Brureau, M., Lebrun, A., Rousset, M. C., Fagni, L., Bockaert, J., de Bock, F., et al. (2011). Epileptiform activity induces vascular remodeling and zonula occludens 1 downregulation in organotypic hippocampal cultures: role of VEGF signaling pathways. J. Neurosci. 31, 10677-10688. doi: 10.1523/JNEUROSCI.5692-10.2011
106. Najjar, S., Pearlman, D., Miller, D. C., and Devinsky, O. (2011). Refractory epilepsy associated with microglial activation. Neurologist 17, 249-254. doi: 10.1097/NRL.0b013e31822aad04
107. Nayak, D., Roth, T. L., and McGavern, D. B. (2014). Microglia development and function. Annu. Rev. Immunol. 32, 367-402. doi: 10.1146/annurev-immunol-032713-120240
108. Neniskyte, U., Vilalta, A., and Brown, G. C. (2014). Tumour necrosis factor alpha-induced neuronal loss is mediated by microglial phagocytosis. FEBS Lett. 588, 2952-2956. doi: 10.1016/j.febslet.2014.05.046
109. Nishioku, T., Matsumoto, J., Dohgu, S., Sumi, N., Miyao, K., Takata, F., et al. (2010). Tumor necrosis factor-alpha mediates the blood-brain barrier dysfunction induced by activated microglia in mouse brain microvascular endothelial cells. J. Pharmacol. Sci. 112, 251-254. doi: 10.1254/jphs.09292sc
110. Obermeier, B., Daneman, R., and Ransohoff, R. M. (2013). Development, maintenance and disruption of the blood-brain barrier. Nat. Med. 19, 1584-1596. doi: 10.1038/nm.3407
111. Perry, V. H., Nicoll, J. A., and Holmes, C. (2010). Microglia in neurodegenerative disease. Nat. Rev. Neurol. 6, 193-201. doi: 10.1038/nrneurol.2010.17
112. Pyter, L. M., Pineros, V., Galang, J. A., McClintock, M. K., and Prendergast, B. J. (2009). Peripheral tumors induce depressive-like behaviors and cytokine production and alter hypothalamic-pituitary-adrenal axis regulation. Proc. Natl. Acad. Sci. U S A 106, 9069-9074. doi: 10.1073/pnas.0811949106
113. Qin, L., Wu, X., Block, M. L., Liu, Y., Breese, G. R., Hong, J. S., et al. (2007). Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 55, 453-462. doi: 10.1002/glia.20467
114. Quan, N., Stern, E. L., Whiteside, M. B., and Herkenham, M. (1999). Induction of pro-inflammatory cytokine mRNAs in the brain after peripheral injection of subseptic doses of lipopolysaccharide in the rat. J. Neuroimmunol. 93, 72-80. doi: 10.1016/s0165-5728(98)00193-3
115. Rajasekaran, S. A., Beyenbach, K. W., and Rajasekaran, A. K. (2008). Interactions of tight junctions with membrane channels and transporters. Biochim. Biophys. Acta 1778, 757-769. doi: 10.1016/j.bbamem.2007.11.007
116. Ransohoff, R. M., and Engelhardt, B. (2012). The anatomical and cellular basis of immune surveillance in the central nervous system. Nat. Rev. Immunol. 12, 623-635. doi: 10.1038/nri3265
117. Ravizza, T., Gagliardi, B., Noé, F., Boer, K., Aronica, E., and Vezzani, A. (2008a). Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy. Neurobiol. Dis. 29, 142-160. doi: 10.1016/j.nbd.2007.08.012
118. Ravizza, T., Noe, F., Zardoni, D., Vaghi, V., Sifringer, M., and Vezzani, A. (2008b). Interleukin converting enzyme inhibition impairs kindling epileptogenesis in rats by blocking astrocytic IL-1beta production. Neurobiol. Dis. 31, 327-333. doi: 10.1016/j.nbd.2008.05.007
119. Readnower, R. D., Chavko, M., Adeeb, S., Conroy, M. D., Pauly, J. R., McCarron, R. M., et al. (2010). Increase in blood-brain barrier permeability, oxidative stress and activated microglia in a rat model of blast-induced traumatic brain injury. J. Neurosci. Res. 88, 3530-3539. doi: 10.1002/jnr.22510
120. Riazi, K., Galic, M. A., Kuzmiski, J. B., Ho, W., Sharkey, K. A., and Pittman, Q. J. (2008). Microglial activation and TNFalpha production mediate altered CNS excitability following peripheral inflammation. Proc. Natl. Acad. Sci. U S A 105, 17151-17156. doi: 10.1073/pnas.0806682105
121. Roberts, T. K., Eugenin, E. A., Lopez, L., Romero, I. A., Weksler, B. B., Couraud, P. O., et al. (2012). CCL2 disrupts the adherens junction: implications for neuroinflammation. Lab. Invest. 92, 1213-1233. doi: 10.1038/labinvest.2012.80
122. Rochfort, K. D., Collins, L. E., Murphy, R. P., and Cummins, P. M. (2014). Downregulation of blood-brain barrier phenotype by proinflammatory cytokines involves NADPH oxidase-dependent ROS generation: consequences for interendothelial adherens and tight junctions. PLoS One 9:e101815. doi: 10.1371/journal.pone.0101815
123. Rodgers, K. M., Hutchinson, M. R., Northcutt, A., Maier, S. F., Watkins, L. R., and Barth, D. S. (2009). The cortical innate immune response increases local neuronal excitability leading to seizures. Brain 132, 2478-2486. doi: 10.1093/brain/awp177
124. Rodriguez, M., Oleszak, E., and Leibowitz, J. (1987). Theiler's murine encephalomyelitis: a model of demyelination and persistence of virus. Crit. Rev. Immunol. 7, 325-365.
125. Rogers, J., Strohmeyer, R., Kovelowski, C. J., and Li, R. (2002). Microglia and inflammatory mechanisms in the clearance of amyloid beta peptide. Glia 40, 260-269. doi: 10.1002/glia.10153
126. Rojo, A. I., McBean, G., Cindric, M., Egea, J., López, M. G., Rada, P., et al. (2014). Redox control of microglial function: molecular mechanisms and functional significance. Antioxid. Redox Signal. 21, 1766-1801. doi: 10.1089/ars.2013.5745
127. Ronaldson, P. T., and Davis, T. P. (2012). Blood-brain barrier integrity and glial support: mechanisms that can be targeted for novel therapeutic approaches in stroke. Curr. Pharm. Des. 18, 3624-3644. doi: 10.2174/138161212802002625
128. Rosenberg, G. A., Cunningham, L. A., Wallace, J., Alexander, S., Estrada, E. Y., Grossetete, M., et al. (2001). Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures. Brain Res. 893, 104-112. doi: 10.1016/s0006-8993(00)03294-7
129. Ruhrberg, C., and Bautch, V. L. (2013). Neurovascular development and links to disease. Cell. Mol. Life Sci. 70, 1675-1684. doi: 10.1007/s00018-013-1277-5
130. Ruhrberg, C., Gerhardt, H., Golding, M., Watson, R., Ioannidou, S., Fujisawa, H., et al. (2002). Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis. Genes Dev.16, 2684-2698. doi: 10.1101/gad.242002
131. Rymo, S. F., Gerhardt, H., Wolfhagen Sand, F., Lang, R., Uv, A., and Betsholtz, C. (2011). A two-way communication between microglial cells and angiogenic sprouts regulates angiogenesis in aortic ring cultures. PLoS One 6:e15846. doi: 10.1371/journal.pone.0015846
132. Ryu, J. K., and McLarnon, J. G. (2009). A leaky blood-brain barrier, fibrinogen infiltration and microglial reactivity in inflamed Alzheimer's disease brain. J. Cell. Mol. Med. 13, 2911-2925. doi: 10.1111/j.1582-4934.2008.00434.x
133. Sandoval, K. E., and Witt, K. A. (2008). Blood-brain barrier tight junction permeability and ischemic stroke.Neurobiol. Dis. 32, 200-219. doi: 10.1016/j.nbd.2008.08.005
134. Schreibelt, G., Kooij, G., Reijerkerk, A., van Doorn, R., Gringhuis, S. I., van der Pol, S., et al. (2007). Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase and PKB signaling. FASEB J. 21, 3666-3676. doi: 10.1096/fj.07-8329com
135. Selvamani, A., Sathyan, P., Miranda, R. C., and Sohrabji, F. (2012). An antagomir to microRNA Let7f promotes neuroprotection in an ischemic stroke model. PLoS One 7:e32662. doi: 10.1371/journal.pone.0032662
136. Sharief, M. K., Ciardi, M., and Thompson, E. J. (1992). Blood-brain barrier damage in patients with bacterial meningitis: association with tumor necrosis factor-alpha but not interleukin-1 β. J. Infect. Dis. 166, 350-358. doi: 10.1093/infdis/166.2.350
137. Shechter, R., and Schwartz, M. (2013). Harnessing monocyte-derived macrophages to control central nervous system pathologies: no longer 'if' but 'how'. J. Pathol. 229, 332-346. doi: 10.1002/path.4106
138. Sloka, S., Metz, L. M., Hader, W., Starreveld, Y., and Yong, V. W. (2013). Reduction of microglial activity in a model of multiple sclerosis by dipyridamole. J. Neuroinflammation 10:89. doi: 10.1186/1742-2094-10-89
139. Smith, J. A., Das, A., Ray, S. K., and Banik, N. L. (2012). Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain Res. Bull. 87, 10-20. doi: 10.1016/j.brainresbull.2011.10.004
140. Sohrabji, F., and Williams, M. (2013). Stroke neuroprotection: oestrogen and insulin-like growth factor-1 interactions and the role of microglia. J. Neuroendocrinol. 25, 1173-1181. doi: 10.1111/jne.12059
141. Spindler, K. R., and Hsu, T. H. (2012). Viral disruption of the blood-brain barrier. Trends Microbiol. 20, 282-290. doi: 10.1016/j.tim.2012.03.009
142. Sriram, S., and Steiner, I. (2005). Experimental allergic encephalomyelitis: a misleading model of multiple sclerosis. Ann. Neurol. 58, 939-945. doi: 10.1002/ana.20743
143. Stamatovic, S. M., Dimitrijevic, O. B., Keep, R. F., and Andjelkovic, A. V. (2006). Protein kinase Calpha-RhoA cross-talk in CCL2-induced alterations in brain endothelial permeability. J. Biol. Chem. 281, 8379-8388. doi: 10.1074/jbc.m513122200
144. Stamatovic, S. M., Keep, R. F., Kunkel, S. L., and Andjelkovic, A. V. (2003). Potential role of MCP-1 in endothelial cell tight junction 'opening': signaling via Rho and Rho kinase. J. Cell Sci. 116, 4615-4628. doi: 10.1242/jcs.00755
145. Stamatovic, S. M., Shakui, P., Keep, R. F., Moore, B. B., Kunkel, S. L., Van Rooijen, N., et al. (2005). Monocyte chemoattractant protein-1 regulation of blood-brain barrier permeability. J. Cereb. Blood Flow Metab. 25, 593-606. doi: 10.1038/sj.jcbfm.9600055
146. Stewart, P. A., and Wiley, M. J. (1981). Developing nervous tissue induces formation of blood-brain barrier characteristics in invading endothelial cells: a study using quail-chick transplantation chimeras. Dev. Biol. 84, 183-192. doi: 10.1016/0012-1606(81)90382-1
147. Strazza, M., Pirrone, V., Wigdahl, B., and Nonnemacher, M. R. (2011). Breaking down the barrier: the effects of HIV-1 on the blood-brain barrier. Brain Res. 1399, 96-115. doi: 10.1016/j.brainres.2011.05.015
148. Sumi, N., Nishioku, T., Takata, F., Matsumoto, J., Watanabe, T., Shuto, H., et al. (2010). Lipopolysaccharide-activated microglia induce dysfunction of the blood-brain barrier in rat microvascular endothelial cells co-cultured with microglia. Cell. Mol. Neurobiol. 30, 247-253. doi: 10.1007/s10571-009-9446-7
149. Takeda, S., Sato, N., and Morishita, R. (2014). Systemic inflammation, blood-brain barrier vulnerability and cognitive/non-cognitive symptoms in Alzheimer disease: relevance to pathogenesis and therapy. Front. Aging Neurosci. 6:171. doi: 10.3389/fnagi.2014.00171
150. Tammela, T., Zarkada, G., Nurmi, H., Jakobsson, L., Heinolainen, K., Tvorogov, D., et al. (2011). VEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signalling. Nat. Cell Biol. 13, 1202-1213. doi: 10.1038/ncb2331
151. Tanaka, S., Ide, M., Shibutani, T., Ohtaki, H., Numazawa, S., Shioda, S., et al. (2006). Lipopolysaccharide-induced microglial activation induces learning and memory deficits without neuronal cell death in rats. J. Neurosci. Res. 83, 557-566. doi: 10.1002/jnr.20752
152. Thornton, P., McColl, B. W., Greenhalgh, A., Denes, A., Allan, S. M., and Rothwell, N. J. (2010). Platelet interleukin-1alpha drives cerebrovascular inflammation. Blood 115, 3632-3639. doi: 10.1182/blood-2009-11-252643
153. Tikka, T., Fiebich, B. L., Goldsteins, G., Keinanen, R., and Koistinaho, J. (2001). Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J. Neurosci. 21, 2580-2588.
154. Town, T., Tan, J., Flavell, R. A., and Mullan, M. (2005). T-cells in Alzheimer's disease. Neuromolecular Med. 7, 255-264. doi: 10.1385/NMM:7:3:255
155. Truettner, J. S., Alonso, O. F., and Dalton Dietrich, W. (2005). Influence of therapeutic hypothermia on matrix metalloproteinase activity after traumatic brain injury in rats. J. Cereb. Blood Flow Metab. 25, 1505-1516. doi: 10.1038/sj.jcbfm.9600150
156. Tu, Y. F., Tsai, Y. S., Wang, L. W., Wu, H. C., Huang, C. C., and Ho, C. J. (2011). Overweight worsens apoptosis, neuroinflammation and blood-brain barrier damage after hypoxic ischemia in neonatal brain through JNK hyperactivation. J. Neuroinflammation 8:40. doi: 10.1186/1742-2094-8-40
157. Ubenauf, K. M., Krueger, M., Henneke, P., and Berner, R. (2007). Lipopolysaccharide binding protein is a potential marker for invasive bacterial infections in children. Pediatr. Infect. Dis. J. 26, 159-162. doi: 10.1097/01.inf.0000253064.88722.6d
158. van Horssen, J., Vos, C. M., Admiraal, L., van Haastert, E. S., Montagne, L., van der Valk, P., et al. (2006). Matrix metalloproteinase-19 is highly expressed in active multiple sclerosis lesions. Neuropathol. Appl. Neurobiol. 32, 585-593. doi: 10.1111/j.1365-2990.2006.00766.x
159. Verderio, C., and Matteoli, M. (2001). ATP mediates calcium signaling between astrocytes and microglial cells: modulation by IFN-gamma. J. Immunol. 166, 6383-6391. doi: 10.4049/jimmunol.166.10.6383
160. Vezzani, A., French, J., Bartfai, T., and Baram, T. Z. (2011). The role of inflammation in epilepsy. Nat. Rev. Neurol.7, 31-40. doi: 10.1038/nrneurol.2010.178
161. Vezzani, A., Ravizza, T., Balosso, S., and Aronica, E. (2008). Glia as a source of cytokines: implications for neuronal excitability and survival. Epilepsia 49(Suppl. 2), 24-32. doi: 10.1111/j.1528-1167.2008.01490.x
162. Wang, L., Lim, E. J., Toborek, M., and Hennig, B. (2008). The role of fatty acids and caveolin-1 in tumor necrosis factor alpha-induced endothelial cell activation. Metabolism 57, 1328-1339. doi: 10.1016/j.metabol.2008.01.036
163. Wang, L. W., Tu, Y. F., Huang, C. C., and Ho, C. J. (2012). JNK signaling is the shared pathway linking neuroinflammation, blood-brain barrier disruption and oligodendroglial apoptosis in the white matter injury of the immature brain. J. Neuroinflammation 9:175. doi: 10.1186/1742-2094-9-175
164. Weaver, A., Goncalves da Silva, A., Nuttall, R. K., Edwards, D. R., Shapiro, S. D., Rivest, S., et al. (2005). An elevated matrix metalloproteinase (MMP) in an animal model of multiple sclerosis is protective by affecting Th1/Th2 polarization. FASEB J. 19, 1668-1670. doi: 10.1096/fj.04-2030fje
165. Wiley, C. A., Schrier, R. D., Nelson, J. A., Lampert, P. W., and Oldstone, M. B. (1986). Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc. Natl. Acad. Sci. U S A 83, 7089-7093. doi: 10.1073/pnas.83.18.7089
166. Willis, C. L. (2011). Glia-induced reversible disruption of blood-brain barrier integrity and neuropathological response of the neurovascular unit. Toxicol. Pathol. 39, 172-185. doi: 10.1177/0192623310385830
167. Witt, K. A., Mark, K. S., Huber, J., and Davis, T. P. (2005). Hypoxia-inducible factor and nuclear factor kappa-B activation in blood-brain barrier endothelium under hypoxic/reoxygenation stress. J. Neurochem. 92, 203-214. doi: 10.1111/j.1471-4159.2004.02871.x
168. Wolburg, H., and Lippoldt, A. (2002). Tight junctions of the blood-brain barrier: development, composition and regulation. Vascul. Pharmacol. 38, 323-337. doi: 10.1016/s1537-1891(02)00200-8
169. Wyss-Coray, T. (2006). Tgf-Beta pathway as a potential target in neurodegeneration and Alzheimer's. Curr. Alzheimer Res. 3, 191-195. doi: 10.2174/156720506777632916
170. Xiong, Y., Zhang, Y., Mahmood, A., Meng, Y., Zhang, Z. G., Morris, D. C., et al. (2012). Neuroprotective and neurorestorative effects of thymosin beta4 treatment initiated 6 hours after traumatic brain injury in rats. J. Neurosurg. 116, 1081-1092. doi: 10.3171/2012.1.jns111729
171. Yamagata, K., Tagami, M., Takenaga, F., Yamori, Y., and Itoh, S. (2004). Hypoxia-induced changes in tight junction permeability of brain capillary endothelial cells are associated with IL-1beta and nitric oxide. Neurobiol. Dis. 17, 491-499. doi: 10.1016/j.nbd.2004.08.001
172. Yang, Y., Estrada, E. Y., Thompson, J. F., Liu, W., and Rosenberg, G. A. (2007). Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J. Cereb. Blood Flow Metab. 27, 697-709. doi: 10.1038/sj.jcbfm.9600375
173. Yang, Y., and Rosenberg, G. A. (2011). Blood-brain barrier breakdown in acute and chronic cerebrovascular disease. Stroke 42, 3323-3328. doi: 10.1161/strokeaha.110.608257
174. Yang, Y. M., Shang, D. S., Zhao, W. D., Fang, W. G., and Chen, Y. H. (2013). Microglial TNF-alpha-dependent elevation of MHC class I expression on brain endothelium induced by amyloid-beta promotes T cell transendothelial migration. Neurochem. Res. 38, 2295-2304. doi: 10.1007/s11064-013-1138-5
175. Yao, Y., and Tsirka, S. E. (2011). Truncation of monocyte chemoattractant protein 1 by plasmin promotes blood-brain barrier disruption. J. Cell Sci. 124, 1486-1495. doi: 10.1242/jcs.082834
176. Yenari, M. A., Xu, L., Tang, X. N., Qiao, Y., and Giffard, R. G. (2006). Microglia potentiate damage to blood-brain barrier constituents: improvement by minocycline in vivo and in vitro. Stroke 37, 1087-1093. doi: 10.1161/01.str.0000206281.77178.ac
177. Yin, X., Wright, J., Wall, T., and Grammas, P. (2010). Brain endothelial cells synthesize neurotoxic thrombin in Alzheimer's disease. Am. J. Pathol. 176, 1600-1606. doi: 10.2353/ajpath.2010.090406
178. Yrjänheikki, J., Keinänen, R., Pellikka, M., Hökfelt, T., and Koistinaho, J. (1998). Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc. Natl. Acad. Sci. U S A 95, 15769-15774. doi: 10.1073/pnas.95.26.15769
179. Yrjänheikki, J., Tikka, T., Keinänen, R., Goldsteins, G., Chan, P. H., and Koistinaho, J. (1999). A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc. Natl. Acad. Sci. U S A 96, 13496-13500. doi: 10.1073/pnas.96.23.13496
180. Zhou, X., Spittau, B., and Krieglstein, K. (2012). TGFbeta signalling plays an important role in IL4-induced alternative activation of microglia. J. Neuroinflammation 9:210. doi: 10.1186/1742-2094-9-210
181. Zipser, B. D., Johanson, C. E., Gonzalez, L., Berzin, T. M., Tavares, R., Hulette, C. M., et al. (2007). Microvascular injury and blood-brain barrier leakage in Alzheimer's disease. Neurobiol. Aging 28, 977-986. doi: 10.1016/j.neurobiolaging.2006.05.016
182. Zlokovic, B. V. (2004). Clearing amyloid through the blood-brain barrier. J. Neurochem. 89, 807-811. doi: 10.1111/j.1471-4159.2004.02385.x
183. Zlokovic, B. V. (2008). The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57, 178-201. doi: 10.1016/j.neuron.2008.01.003
184. Zlokovic, B. V. (2011). Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders.Nat. Rev. Neurosci. 12, 723-738. doi: 10.1038/nrn3114